| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/26/2001 | EP1135130A1 Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia |
| 09/26/2001 | EP1135129A1 Use of n-substituted azaheterocyclic compounds for the manufacture of a pharmaceutical composition for the treatment of indications related to angiogenesis |
| 09/26/2001 | EP1135128A2 Novel method of treatment |
| 09/26/2001 | EP1135127A1 New pharmaceutical composition and the process for its preparation |
| 09/26/2001 | EP1135126A2 Myt1 kinase inhibitors |
| 09/26/2001 | EP1135125A1 Controlled-release dosage forms comprising zolpidem or a salt thereof |
| 09/26/2001 | EP1135124A2 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituded indolealkanoic acids |
| 09/26/2001 | EP1135123A1 Use of isatin derivatives as ion channel activating agents |
| 09/26/2001 | EP1135122A2 Use of amtolmetin guacyl as an antiinflammatory drug |
| 09/26/2001 | EP1135121A2 Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain |
| 09/26/2001 | EP1135120A2 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| 09/26/2001 | EP1135119A1 Glucose and lipid lowering compounds |
| 09/26/2001 | EP1135118A1 Dispersible compositions containing l-dopa ethyl ester |
| 09/26/2001 | EP1135117A1 Method of treating chronic obstructive pulmonary disease |
| 09/26/2001 | EP1135116A1 Use of poly (hexamethylene) biguanide for producing an agent for promoting the healing of uninfected wounds |
| 09/26/2001 | EP1135115A2 Use of sibutramine for the treatment of disorders of the central nervous system secondary to organic impairments |
| 09/26/2001 | EP1135114A1 Method for reducing free-radical induced injury |
| 09/26/2001 | EP1135113A1 Treatment of parkinson's disease with oligonucleotides |
| 09/26/2001 | EP1135112A1 An oral formulation for gastrointestinal drug delivery |
| 09/26/2001 | EP1135111A2 Autoadhesive oral transmucosal delivery dosage form |
| 09/26/2001 | EP1135110A1 Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses |
| 09/26/2001 | EP1135106A1 Sustained release matrix systems for highly soluble drugs |
| 09/26/2001 | EP1135036A1 Smoking products containing antioxidants |
| 09/26/2001 | EP1135026A1 Novel methods of protecting plants from pathogens |
| 09/26/2001 | EP1064002B1 Use of sphingosin-1-phosphate, sphingosin-1-phosphate derivatives and/or mixtures thereof for the treatment of inflammatory diseases of the skin |
| 09/26/2001 | EP1031570A4 Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting immuno-deficiency |
| 09/26/2001 | EP1003499B1 Diclofenac solution for topical application |
| 09/26/2001 | EP0988033B1 Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation |
| 09/26/2001 | EP0966426B1 Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them |
| 09/26/2001 | EP0909271B1 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 09/26/2001 | EP0904088A4 Gas- or gel-filled silicone cushion for treatment of keloid and hypertrophic scars |
| 09/26/2001 | EP0888772B1 Sustained-release metal valproate tablets |
| 09/26/2001 | EP0839026B1 Polyether block copolymer micellar compositions for targeting biological agents |
| 09/26/2001 | EP0836591B1 Semicarbazones having cns activity and pharmaceutical preparations containing same |
| 09/26/2001 | EP0833825B1 6-carboxamido dihydropyran derivatives |
| 09/26/2001 | EP0825860B1 Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients |
| 09/26/2001 | EP0805685B1 Novel antifungal cyclohexapeptides |
| 09/26/2001 | EP0800505B1 Novel immunotherapeutic aryl amides |
| 09/26/2001 | EP0795326B1 Ocular tension depressant |
| 09/26/2001 | EP0776198B1 Transdermal therapeutic system with protection against hydrolysis |
| 09/26/2001 | EP0775141B1 Phenyl xanthine derivatives |
| 09/26/2001 | EP0773943B1 Compounds useful as antiproliferative agents and garft inhibitors |
| 09/26/2001 | EP0773932B1 Benzenesulfonamide derivatives used as bradykinine antagonists |
| 09/26/2001 | EP0762887B1 Acylated enol derivatives as prodrugs of elastase inhibitors |
| 09/26/2001 | EP0738727B1 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof |
| 09/26/2001 | EP0735864B1 Method for preparing low dose pharmaceutical products |
| 09/26/2001 | EP0723436B1 Multiple unit tableted dosage form i |
| 09/26/2001 | EP0707591B1 Methylphosphonic acid ester, process for preparing the same and its use |
| 09/26/2001 | EP0626968B1 Piperidinyl thiacyclic derivatives |
| 09/26/2001 | EP0528991B1 Detectably labelled marker component comprising a fluorophore moiety , fluorescent probe comprising the marker component and uses thereof. |
| 09/26/2001 | CN1314999A Modulating multiple lineage kinase proteins |
| 09/26/2001 | CN1314912A Tartrate salt of a sabstituted dipentide as growth hormone secretagogue |
| 09/26/2001 | CN1314910A Adenosine derivatives |
| 09/26/2001 | CN1314909A Aryl phosphate derivatives of d4T having anti-HIV activity |
| 09/26/2001 | CN1314906A Salts of paroxetine |
| 09/26/2001 | CN1314905A Muscarinic antagonists |
| 09/26/2001 | CN1314904A Alkynyl-substituted quinoline-2-one derivatives useful as anticancer agents |
| 09/26/2001 | CN1314901A Methods for separating tocol from tocol-containing mixture |
| 09/26/2001 | CN1314900A Particle-formijng compositions containing fused pyrrolocarbazoles |
| 09/26/2001 | CN1314895A Substituted piperazones and their therapeutic use |
| 09/26/2001 | CN1314893A IL-8 receptor antanonists |
| 09/26/2001 | CN1314890A Cyanoguanidines as cell proliferation inhibitors |
| 09/26/2001 | CN1314888A Crystalline forms of osanetant |
| 09/26/2001 | CN1314887A Ester of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and their use as prodrugs of the 5HT2A receptor antagonist MDL 110,907 |
| 09/26/2001 | CN1314884A 2,5-substituted benzoluslfonylureas and thioureas, methods for production thereof, use thereof and pharamceutical preparations containing the same |
| 09/26/2001 | CN1314883A Amino acid derivatives and drug containing the same as the active ingredient |
| 09/26/2001 | CN1314882A NAALADase inhibitors useful as pharmaceutical compound and compositions |
| 09/26/2001 | CN1314815A Immunodulatory drug composition |
| 09/26/2001 | CN1314814A Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperdines)-butylazols in preparation of a medicament for the treamtent of pain |
| 09/26/2001 | CN1314813A Novel isoxazolinone antibacterial agent |
| 09/26/2001 | CN1314812A Formulations for controlling human lice |
| 09/26/2001 | CN1314811A Therapies for treating pulmonary diseases |
| 09/26/2001 | CN1314810A Perfusate preparation for ophthalmic operation |
| 09/26/2001 | CN1314468A Relative new gene of DiGeorge syndrome and its protein |
| 09/26/2001 | CN1314358A Method for preparing erythromycin derivative |
| 09/26/2001 | CN1314352A Soya aglycone-3'-sodium sulfonate and its preparing method and medicinal use |
| 09/26/2001 | CN1314349A Metronizole succinic acid monoester sodium and potassium salt and preparing method and use |
| 09/26/2001 | CN1314345A Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them |
| 09/26/2001 | CN1314177A Medicine for treating high blood pressure and preventing cerebral hemorrhage and its preparing method |
| 09/26/2001 | CN1314160A Oral pill for curing diabetes and its complication |
| 09/26/2001 | CN1314154A Traditional Chinese medicine external preparation for curing piles |
| 09/26/2001 | CN1314152A Use of nitrophenyl salicyl amine as spermicide |
| 09/26/2001 | CN1314151A Use of AFMK in preparing medicine with free radical cloaning function |
| 09/26/2001 | CN1314150A Film coating agent for perioral skin |
| 09/26/2001 | CN1314149A New use of tea polyphenols and its oxide for treating hepatopathy |
| 09/26/2001 | CN1314148A New use of tea polyphenols for treating prostatosis |
| 09/26/2001 | CN1071760C N-terminally chemically modified protein composition and methods |
| 09/26/2001 | CN1071755C Heterocyclyycarboxamide derivatives and their use as therapeutic agents |
| 09/26/2001 | CN1071753C 7-azabicyclo [2,2,1]-heptane and heptene derivatives as cholinergic receptor ligands |
| 09/26/2001 | CN1071752C Substituted thiophenesulfonylureas and-thioureas, processes for thei preparation, their use as medicament or diagnostic, and medicament containing them |
| 09/26/2001 | CN1071751C Reversible protease inhibitors |
| 09/26/2001 | CN1071746C Amidine derivatives with nitric oxide synthetase activities |
| 09/26/2001 | CN1071743C Sulfuryl or sulfufiny/benzoyl guanidine derivative |
| 09/26/2001 | CN1071741C O-carbamoyl-phenylalanimol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same |
| 09/26/2001 | CN1071740C Nitro-benzamides useful as anti-arrhythmic agents |
| 09/26/2001 | CN1071738C Carboxylic derivatives exhibiting phospholipase A2 inhibitory activity |
| 09/26/2001 | CN1071574C Use of 1 alpha, 24-dihydroxy vitamin D2 |
| 09/26/2001 | CN1071573C Anti-atteroscherotic use of 17 alpha-dihydroeoquilin |
| 09/26/2001 | CN1071572C Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection |
| 09/26/2001 | CN1071571C Composition comprising a tramadol material and acetaminophen and its use |